Middle East and Africa Sleep Disorder Treatment Market, By Type (Insomnia, Sleep Apnea, Restless Legs Syndrome (RLS), Narcolepsy and Others), Treatment (Pharmacological Therapy, Mechanical Therapy, Mandibular Advancement Devices, Hypoglossal Nerve Stimulator, Surgery and Others) Route of Administration (Oral, Parenteral and Others), Drugs Type (Branded and Generics), Population Type (Children and Adults), End User (Hospitals, Specialty Clinics, Home Healthcare, Ambulatory Surgical Center and Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others), Country (South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Middle East and Africa Sleep Disorder Treatment Market
The sleep disorder treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 7.0% in the forecast period of 2021 to 2028 and is expected to reach USD 372.83 million by 2028. The increased prevalence of sleep disorders such as sleep apnea, insomnia and narcolepsy across the globe is driving the sleep disorder treatment market.
Sleep disorder such as sleep apnea, narcolepsy or insomnia are medical disorder in which the patient has difficulty with maintenance of sleep or sleep initiation. This disorder causes irregular mental, physical, social and emotional functions. Sleep disorders are treated via different treatment options according to the symptoms of the patients. Most of the sleep apnea patients are treated via mechanical therapies.
The increased sleep disorder will increase the demand for sleep disorder treatment options. Thus, increase in mental stress due to hectic life & unhealthy habits are anticipated to propel the growth of the sleep disorder treatment market. The extent of side effects could be life threatening causing fear of consumption in patients, thus it leads to decreased sales and demand. Thereby, adverse effect of drugs acts as restraining factor for the growth of the sleep disorder treatment market. The growing technological advancement is acting as an opportunity for boosting the demand of sleep disorder treatment market. The high cost of sleep disorder treatment acts as a challenge for the growth of the sleep disorder treatment market.
The sleep disorder treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the sleep disorder treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Sleep Disorder Treatment Market Scope and Market Size
The sleep disorder treatment market is categorized into seven notable segments which are based on the type, treatment, route of administration, drugs type, population type, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of type, the sleep disorder treatment market is segmented into insomnia, sleep apnea, restless legs syndrome (RLS), narcolepsy and others. In 2021, insomnia segment is expected to dominate the sleep disorder treatment market because of the technological advancement in order to develop innovative treatment options for the particular disorder.
- On the basis of treatment, the sleep disorder treatment market is segmented into pharmacological therapy, mechanical therapy, mandibular advancement devices, hypoglossal nerve stimulator, surgery and others. In 2021, pharmacological therapy segment is expected to dominate the sleep disorder treatment market because numerous classes of medications are available for the treatment of sleep disorder as per the symptoms of patients.
- On the basis of route of administration, the sleep disorder treatment market is segmented into oral, parenteral and others. In 2021, oral segment is expected to dominate the sleep disorder treatment market because of the increased availability of oral drugs for the treatment of sleep disorders such as narcolepsy, restless legs syndrome (RLS) and insomnia among others.
- On the basis of drugs type, the sleep disorder treatment market is segmented into branded and generics. In 2021, generics segment is expected to dominate the sleep disorder treatment market because of the increased availability of generic drugs for the treatment of sleep disorders such as gabapentin, zolpidem ER tablets and eszopiclone tablets, CIV among others.
- On the basis of population type, the sleep disorder treatment market is segmented into children and adults. In 2021, adults segment is expected to dominate the sleep disorder treatment market due to the surging geriatric population across globe requiring more advanced treatment options.
- On the basis of end user, the sleep disorder treatment market is segmented into hospitals, specialty clinics, home healthcare, ambulatory surgical center and others. In 2021, hospitals segment is expected to dominate the sleep disorder treatment market due to the financial capabilities of hospitals to purchase expensive equipment used in surgery along with the presence of trained professionals to operate the mechanical devices and prescribed medications.
- On the basis of distribution channel, the sleep disorder treatment market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others. In 2021, direct tender segment is expected to dominate the sleep disorder treatment market as most of the drugs are procured through direct tender services.
Middle East and Africa Sleep Disorder Treatment Market Country Level Analysis
Middle East and Africa sleep disorder treatment market is analysed and market size information is provided by the country, type, treatment, route of administration, drugs type, population type, end user and distribution channel as referenced above.
The countries covered in the Middle East and Africa sleep disorder treatment market report are South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel and rest of Middle East and Africa.
Saudi Arabia is dominating in the Middle East and Africa sleep disorder treatment market due to technological advancements in the country along with the presence of major players of sleep disorder treatment in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
New Product Launches by Manufacturers is Creating New Opportunities for Players in the Sleep Disorder Treatment Market
The sleep disorder treatment market also provides you with detailed market analysis for every country growth in aesthetic industry with sleep disorder treatment market sales, impact of advancement in the sleep disorder treatment market and changes in regulatory scenarios with their support for the sleep disorder treatment market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Sleep Disorder Treatment Market Share Analysis
The sleep disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to sleep disorder treatment market.
The major players covered in the Middle East and Africa sleep disorder treatment market report are Jazz Pharmaceuticals, Inc., Pfizer Inc., Viatris Inc., Hikma Pharmaceuticals PLC, Taj Pharmaceuticals Limited, Mallinckrodt, Alembic Pharmaceuticals Limited, Dr. Reddy’s Laboratories Ltd., Koninklijke Philips N.V., ResMed among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the sleep disorder treatment market.
For instance,
- In September 2020, Jazz Pharmaceuticals, Inc. announced the collaboration with American Heart Association's sleep health educational content in order to strengthen its sleep heath therapeutic area. This new collaboration done by the company has increased its credibility in the market.
Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the sleep disorder treatment market which also provides the benefit for organisation to improve their offering for sleep disorder treatment.
SKU-